One of the stumbling blocks of treating MCL is accompanied by the deregulation of Bcl-2, Mcl-1 and BIM or inactivation of Apaf-1, thereby allowing these cells to evade caspase-mediated apoptosis [33, 34]. This evidence concerns the gene BCL2 and mantle cell lymphoma.